Pigmented contact dermatitis and hair dyes: A retrospective case-control multicentre study in Korea.


Journal

Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 13 11 2022
accepted: 26 06 2023
medline: 29 11 2023
pubmed: 2 8 2023
entrez: 1 8 2023
Statut: ppublish

Résumé

Pigmented contact dermatitis (PCD), a rare variant of non-eczematous contact dermatitis, is clinically characterized by sudden-onset brown or grey pigmentation on the face and neck. It is hypothesized to be caused by repeated contact with low levels of allergens. This study evaluated the risk of using hair dyes in patients with PCD in Korea. A total of 1033 PCD patients and 1366 controls from 31 university hospitals were retrospectively recruited. We collected and analysed the data from the patient group, diagnosed through typical clinical findings of PCD and the control group, which comprised age/sex-matched patients who visited the participating hospitals with pre-existing skin diseases other than current allergic disease or PCD. Melasma and photosensitivity were significantly more common in the control group, and a history of contact dermatitis was more common in the PCD group. There were significantly more Fitzpatrick skin type V participants in the PCD group than in the control group. There was no significant difference in sunscreen use between the groups. Using dermatologic medical history, Fitzpatrick skin type and sunscreen use as covariates, we showed that hair dye use carried a higher PCD risk (odds ratio [OR] before adjustment: 2.06, confidence interval [CI]: 1.60-2.65; OR after adjustment: 2.74, CI: 1.88-4.00). Moreover, henna users had a higher risk of PCD (OR before adjustment: 5.51, CI: 4.07-7.47; OR after adjustment: 7.02, CI: 4.59-10.74), indicating a significant increase in the risk of PCD with henna dye use. Contact dermatitis history was more prevalent in henna users than in those using other hair dyes in the PCD group (17.23% vs. 11.55%). Hair dye use is a risk factor for PCD. The risk significantly increased when henna hair dye was used by those with a history of contact dermatitis.

Sections du résumé

BACKGROUND BACKGROUND
Pigmented contact dermatitis (PCD), a rare variant of non-eczematous contact dermatitis, is clinically characterized by sudden-onset brown or grey pigmentation on the face and neck. It is hypothesized to be caused by repeated contact with low levels of allergens.
OBJECTIVES OBJECTIVE
This study evaluated the risk of using hair dyes in patients with PCD in Korea.
METHODS METHODS
A total of 1033 PCD patients and 1366 controls from 31 university hospitals were retrospectively recruited. We collected and analysed the data from the patient group, diagnosed through typical clinical findings of PCD and the control group, which comprised age/sex-matched patients who visited the participating hospitals with pre-existing skin diseases other than current allergic disease or PCD.
RESULTS RESULTS
Melasma and photosensitivity were significantly more common in the control group, and a history of contact dermatitis was more common in the PCD group. There were significantly more Fitzpatrick skin type V participants in the PCD group than in the control group. There was no significant difference in sunscreen use between the groups. Using dermatologic medical history, Fitzpatrick skin type and sunscreen use as covariates, we showed that hair dye use carried a higher PCD risk (odds ratio [OR] before adjustment: 2.06, confidence interval [CI]: 1.60-2.65; OR after adjustment: 2.74, CI: 1.88-4.00). Moreover, henna users had a higher risk of PCD (OR before adjustment: 5.51, CI: 4.07-7.47; OR after adjustment: 7.02, CI: 4.59-10.74), indicating a significant increase in the risk of PCD with henna dye use. Contact dermatitis history was more prevalent in henna users than in those using other hair dyes in the PCD group (17.23% vs. 11.55%).
CONCLUSION CONCLUSIONS
Hair dye use is a risk factor for PCD. The risk significantly increased when henna hair dye was used by those with a history of contact dermatitis.

Identifiants

pubmed: 37528459
doi: 10.1111/jdv.19395
doi:

Substances chimiques

Hair Dyes 0
Sunscreening Agents 0
lawsone TLH4A6LV1W

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2543-2549

Subventions

Organisme : Ministry of Food and Drug Safety
ID : 20172MFDS257

Informations de copyright

© 2023 European Academy of Dermatology and Venereology.

Références

Wang L, Xu AE. Four views of Riehl's melanosis: clinical appearance, dermoscopy, confocal microscopy and histopathology. J Eur Acad Dermatol Venereol. 2014;28:1199-1206.
Nakayama H, Harada R, Toda M. Pigmented cosmetic dermatitis. Int J Dermatol. 1976;15:673-675.
rorsman H. Riehl's melanosis. Int J Dermatol. 1982;21:75-78.
Pires MC, Silva M, dos Reis V, Mitelmann R, Moreira F. Pigmented contact dermatitis due to Plathymenia foliosa dust. Contact Dermatitis. 1999;40:339.
Khanna N, Rasool S. Facial melanoses: Indian perspective. Indian J Dermatol Venereol Leprol. 2011;77:552-563; quiz 564.
Perez-Bernal A, Munoz-Perez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 2000;1:261-268.
Woo YR, Kim JS, Lim JH, Choi JY, Kim M, Yu DS, et al. Acquired diffuse slate-grey facial dyspigmentation due to henna: an unrecognized cause of pigment contact dermatitis in Korean patients. Eur J Dermatol. 2018;28:644-648.
On HR, Hong WJ, Roh MR. Low-pulse energy Q-switched Nd:YAG laser treatment for hair-dye-induced Riehl's melanosis. J Cosmet Laser Ther. 2015;17:135-138.
Bishnoi A, Vinay K, Arshdeep, Parsad D, Handa S, Saikia UN, et al. Contact sensitization to hair colours in acquired dermal macular hyperpigmentation: results from a patch and photo-patch test study of 108 patients. J Eur Acad Dermatol Venereol. 2019;33:1349-1357.
Kim SM, Lee ES, Sohn S, Kim YC. Histopathological features of Riehl melanosis. Am J Dermatopathol. 2020;42:117-121.
Lee YJ, Park JH, Lee D-Y, Lee J-H. Acquired bilateral dyspigmentation on face and neck: clinically appropriate approaches. J Korean Med Sci. 2016;31:2042-2050.
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, et al. A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis. Int J Dermatol. 2019;58:263-272.
Vinay K, Bishnoi A, Kamat D, Chatterjee D, Kumaran MS, Parsad D. Acquired dermal macular hyperpigmentation: an update. Indian Dermatol Online J. 2021;12(5):663-673.
Han JH, Lee HJ, Bang CH, Lee JH, Park YM, Lee JY. P-Phenylenediamine hair dye allergy and its clinical characteristics. Ann Dermatol. 2018;30:316-321.
Shin JW, Choi JY, Huh CH, Na JI. Two cases of pigmented contact dermatitis caused by pure henna hair dyes. Ann Dermatol. 2018;30:735-737.
de Groot AC. Side-effects of henna and semi-permanent ‘black henna’ tattoos: a full review. Contact Dermatitis. 2013;69:1-25.
Meghana V, Gopinath H, Karthikeyan K, Venugopal V. Face and neck pigmentary alterations in hair dye users: a cross-sectional study from South India. Indian Dermatol Online J. 2020;11:760-765.

Auteurs

Myoung Shin Kim (MS)

Department of Dermatology, Sanggye Paik Hospital, School of Medicine, Inje University, Seoul, South Korea.

Bo Young Chung (BY)

Department of Dermatology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.

Sung Eun Chang (SE)

Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Sang Ho Oh (SH)

Department of Dermatology, Severance Hospital and Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea.

Hwa Jung Ryu (HJ)

Department of Dermatology, College of Medicine, Korea University, Ansan Hospital, Ansan, South Korea.

Dong Hyun Kim (DH)

Department of Dermatology, Bundang Medical Center, School of Medicine, CHA University, Seongnam, South Korea.

June Hyunkyung Lee (JH)

Department of Dermatology, Eulji Medical Center, College of Medicine, Eulji University, Seoul, South Korea.

Joo Yeon Ko (JY)

Department of Dermatology, Hanyang University College of Medicine and Hanyang University Seoul Hospital, Seoul, South Korea.

Jeong Eun Kim (JE)

Department of Dermatology, Hanyang University College of Medicine and Hanyang University Seoul Hospital, Seoul, South Korea.

Jong Hee Lee (JH)

Department of Dermatology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul, South Korea.

Ga Young Lee (GY)

Department of Dermatology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Jiehyun Jeon (J)

Department of Dermatology, Guro Hospital, Korea University College of Medicine, Seoul, South Korea.

Hoon Choi (H)

Department of Dermatology, Chosun University Hospital, Gwangju, South Korea.

Mi Ryung Roh (MR)

Department of Dermatology, Gangnam Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea.

Jung Min Bae (JM)

Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

Jung-Im Na (JI)

Department of Dermatology, Seoul National University Bundang Hospital, Seongnam, South Korea.

Hye Jung Jung (HJ)

Department of Dermatology, National Medical Center, Seoul, South Korea.

Chul Hwan Bang (CH)

Department of Dermatology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.

Hei Sung Kim (HS)

Department of Dermatology, Incheon St. Mary's Hospital, The Catholic University of Korea, Incheon, South Korea.

Seung Ho Lee (SH)

Department of Dermatology, Dongguk University Ilsan Hospital, College of Medicine, Dongguk University, Goyang, South Korea.

Min Kyung Shin (MK)

Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, South Korea.

Si-Hyung Lee (SH)

Department of Dermatology, Seoul National University Hospital, Seoul, South Korea.

Kui Young Park (KY)

Department of Dermatology, Chung-Ang University College of Medicine, Seoul, South Korea.

Chul-Jong Park (CJ)

Department of Dermatology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, South Korea.

Mira Choi (M)

Department of Dermatology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, South Korea.

Tae-Jin Yoon (TJ)

Department of Dermatology, School of Medicine, Gyeongsang National University & Hospital, Jinju, South Korea.

Kee Suck Suh (KS)

Department of Dermatology, Kosin University College of Medicine, Busan, South Korea.

Young Lip Park (YL)

Department of Dermatology, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea.

Young Wook Ryoo (YW)

Department of Dermatology, School of Medicine, Keimyung University, Daegu, South Korea.

Myung Hwa Kim (MH)

Department of Dermatology, College of Medicine, Dankook University, Cheonan, South Korea.

You Chan Kim (YC)

Department of Dermatology, Ajou University School of Medicine, Suwon, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH